David V. Goeddel, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 300 shares at $4.98 ($1K) on 2022-12-12, disclosed to the SEC on 2022-12-14.
Open-market purchase of $1k NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| NGM | BUY | 2023-11-17 | $18K | — | Filing → |
| TNYA | BUY | 2023-03-14 | $18K | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |